Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
NTRA
|
Solomon Moshkevich
PRESIDENT, CLINICALDIAGNOSTICS |
SELL
Open market or private sale
|
Direct | 293 Reduced 0.2% |
$68,855
$235.0 p/Share
|
Jan 21
2026 |
|
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 438 Reduced 0.19% |
$102,930
$235.0 p/Share
|
Jan 21
2026 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct | 3,163 Reduced 1.18% |
$743,241
$234.98 p/Share
|
Jan 21
2026 |
|
TKO
|
Seth D Krauss |
SELL
Open market or private sale
|
Direct | 14,016 Reduced 86.06% |
$2,817,496
$201.02 p/Share
|
Jan 21
2026 |
|
AZZ
|
Tara D Mackey
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 2,790 Reduced 9.93% |
$353,325
$126.64 p/Share
|
Jan 21
2026 |
|
SFIX
|
Casey O'Connor
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 13,852 Reduced 2.49% |
$73,969
$5.34 p/Share
|
Jan 21
2026 |
|
CRMD
|
Janet Dillione
Director |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 20.63% |
$68,800
$6.88 p/Share
|
Jan 21
2026 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 37,175 Reduced 36.7% |
$8,878,505
$238.83 p/Share
|
Jan 21
2026 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 1,590 Reduced 0.72% |
$373,650
$235.0 p/Share
|
Jan 21
2026 |
|
UAA
|
V Prem Et Al Watsa
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 5,000,000 Added 0.0% |
$29,450,000
$5.89 p/Share
|
Jan 21
2026 |
|
WRB
|
Mitsui Sumitomo Insurance CO LTD |
BUY
Open market or private purchase
|
Direct | 320,000 Added 0.59% |
$21,526,400
$67.27 p/Share
|
Jan 21
2026 |
|
AGE
|
Randall Moreadith
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 100.0% |
$6,000
$3.0 p/Share
|
Jan 21
2026 |
|
OM
|
John L. Brottem
General Counsel |
SELL
Open market or private sale
|
Direct | 1,180 Reduced 3.19% |
$5,911
$5.01 p/Share
|
Jan 21
2026 |
|
OM
|
Marc Nash
EVP Operations R&D & Service |
SELL
Open market or private sale
|
Direct | 980 Reduced 2.29% |
$4,880
$4.98 p/Share
|
Jan 21
2026 |
|
CABA
|
Steve Gavel
Chief Commercial Officer |
BUY
Open market or private purchase
|
Direct | 22,170 Added 50.0% |
$50,325
$2.27 p/Share
|
Jan 21
2026 |
|
CABA
|
Shawn Tomasello |
BUY
Open market or private purchase
|
Indirect | 22,725 Added 0.0% |
$50,222
$2.21 p/Share
|
Jan 21
2026 |
|
CABA
|
Gwendolyn Binder
President, Science & Tech. |
BUY
Open market or private purchase
|
Direct | 11,312 Added 26.54% |
$24,773
$2.19 p/Share
|
Jan 21
2026 |
|
CABA
|
David J. Chang
Chief Medical Officer |
BUY
Open market or private purchase
|
Direct | 8,800 Added 50.0% |
$19,887
$2.26 p/Share
|
Jan 21
2026 |
|
CABA
|
Michael Gerard
General Counsel |
BUY
Open market or private purchase
|
Direct | 6,600 Added 50.0% |
$14,982
$2.27 p/Share
|
Jan 21
2026 |
|
CABA
|
Mark Simon |
BUY
Open market or private purchase
|
Direct | 11,061 Added 6.99% |
$25,219
$2.28 p/Share
|
Jan 21
2026 |
|
CABA
|
Steven Nichtberger
President & CEO |
BUY
Open market or private purchase
|
Direct | 45,000 Added 4.18% |
$100,800
$2.24 p/Share
|
Jan 21
2026 |
|
OM
|
Leslie Trigg
Chair and CEO |
SELL
Open market or private sale
|
Direct | 2,120 Reduced 1.97% |
$10,706
$5.05 p/Share
|
Jan 21
2026 |
|
CABA
|
Catherine Bollard |
BUY
Open market or private purchase
|
Direct | 4,405 Added 44.9% |
$9,999
$2.27 p/Share
|
Jan 21
2026 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Indirect | 600 Reduced 0.0% |
$44,040
$73.4 p/Share
|
Jan 21
2026 |
|
PB
|
Ned S Holmes |
SELL
Open market or private sale
|
Direct | 500 Reduced 0.59% |
$36,720
$73.44 p/Share
|
Jan 21
2026 |
|
GME
|
Alain Attal
Director |
BUY
Open market or private purchase
|
Direct | 12,000 Added 1.97% |
$259,560
$21.63 p/Share
|
Jan 21
2026 |
|
CLNN
|
Chidozie Ugwumba
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 12,119 Reduced 0.0% |
$61,200
$5.05 p/Share
|
Jan 21
2026 |
|
LNW
|
Fine Capital Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 1,473 Reduced 0.0% |
$169,409
$115.01 p/Share
|
Jan 21
2026 |
|
WDC
|
Cynthia L Tregillis
Chief Legal Officer & Corp Sec |
SELL
Open market or private sale
|
Direct | 447 Reduced 0.31% |
$102,363
$229.0 p/Share
|
Jan 21
2026 |
|
BCDA
|
Peter Altman
President and CEO |
BUY
Open market or private purchase
|
Direct | 300 Added 0.11% |
$402
$1.34 p/Share
|
Jan 21
2026 |
|
UWMC
|
Ishbia Mat
President and CEO |
SELL
Open market or private sale
|
Indirect | 632,874 Reduced 0.0% |
$3,639,025
$5.75 p/Share
|
Jan 21
2026 |
|
IPGP
|
Ip Fibre Devices LTD
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 13,381 Reduced 0.2% |
$1,083,727
$80.99 p/Share
|
Jan 21
2026 |
|
IPGP
|
Eugene A Shcherbakov
Director |
SELL
Open market or private sale
|
Direct | 2,700 Reduced 4.35% |
$217,134
$80.42 p/Share
|
Jan 21
2026 |
|
OUT
|
Manuel A. Diaz
Director |
SELL
Open market or private sale
|
Direct | 11,271 Reduced 19.17% |
$276,026
$24.49 p/Share
|
Jan 21
2026 |
|
ABEO
|
Mark Alvino
Director |
SELL
Open market or private sale
|
Direct | 13,500 Reduced 21.69% |
$70,605
$5.23 p/Share
|
Jan 21
2026 |
|
VTS
|
Robert W Gerrity
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 36,785 Reduced 9.0% |
$723,193
$19.66 p/Share
|
Jan 21
2026 |
|
VTS
|
Brian Cree
President |
SELL
Open market or private sale
|
Direct | 1,440 Reduced 0.31% |
$28,353
$19.69 p/Share
|
Jan 21
2026 |
|
IDCC
|
Lawrence Liren Chen
President and CEO |
SELL
Open market or private sale
|
Direct | 2,975 Reduced 1.84% |
$971,962
$326.71 p/Share
|
Jan 21
2026 |
|
ROC
|
Michael Wayne Domino Jr.
President, DTR Division |
SELL
Open market or private sale
|
Direct | 24,996 Reduced 1.71% |
$99,984
$4.0 p/Share
|
Jan 21
2026 |
|
IRIX
|
Romeo R Dizon
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 2,159 Added 2.1% |
$3,260
$1.51 p/Share
|
Jan 21
2026 |
|
XCUR
|
Hi Tron Systems Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 258,367 Reduced 13.91% |
$1,162,651
$4.5 p/Share
|
Jan 21
2026 |
|
IVFH
|
Robert William Bennett |
SELL
Open market or private sale
|
Direct | 2,600 Reduced 0.64% |
$1,118
$0.43 p/Share
|
Jan 20
2026 |
|
UTHR
|
Michael Benkowitz
PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect | 14,625 Reduced 0.0% |
$6,788,632
$464.18 p/Share
|
Jan 20
2026 |
|
UTHR
|
Michael Benkowitz
PRESIDENT AND COO |
SELL
Open market or private sale
|
Indirect | 7,875 Reduced 0.0% |
$3,655,417
$464.18 p/Share
|
Jan 20
2026 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,365 Added 0.0% |
$14,400
$10.55 p/Share
|
Jan 20
2026 |
|
RPRX
|
Terrance P. Coyne
EVP & CFO |
SELL
Open market or private sale
|
Indirect | 69,582 Reduced 0.0% |
$2,738,051
$39.35 p/Share
|
Jan 20
2026 |
|
ISBA
|
Brian Roy Sackett
Director |
BUY
Open market or private purchase
|
Direct | 403 Added 8.83% |
$19,980
$49.58 p/Share
|
Jan 20
2026 |
|
ISBA
|
Sarah R Opperman
Director |
BUY
Open market or private purchase
|
Direct | 277 Added 1.12% |
$13,733
$49.58 p/Share
|
Jan 20
2026 |
|
ISBA
|
David Brian Behen
Director |
BUY
Open market or private purchase
|
Direct | 242 Added 28.4% |
$11,998
$49.58 p/Share
|
Jan 20
2026 |
|
ISBA
|
Jae A Evans
Director |
BUY
Open market or private purchase
|
Direct | 201 Added 0.74% |
$9,965
$49.58 p/Share
|
Jan 20
2026 |